A Phase I study of iPS-NKT cell intra-arterial infusion therapy in patients with recurrent or advanced head and neck cancer

General Information
Clinical trials phase	Phase 1
Start date (estimated)	2020-09-11
Clinical feature	Label head and neck cancer Link http://purl.obolibrary.org/obo/DOID_11934 Description An organ system cancer that arises in the head or neck region. This region includes the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx.
Administrative Information
ICTRP weblink	https://trialsearch.who.int/Trial2.aspx?TrialID=JPRN-jRCT2033200116
Other study identifiers	Name jRCT2033200116 Description Japan Registry of Clinical Trials (jRCT)
Source weblink	https://jrct.niph.go.jp/en-latest-detail/jRCT2033200116
Cells
Which differentiated cell type is used	Label natural killer cell Link http://purl.obolibrary.org/obo/CL_0000623 Description A lymphocyte that can spontaneously kill a variety of target cells without prior antigenic activation via germline encoded activation receptors and also regulate immune responses via cytokine release and direct contact with other cells.
Recruitment
Recruitment Status	Recruiting
Estimated number of participants	9
Contact institutions/departments	Chiba University